Clarissa Corinaldesi

941 total citations
21 papers, 584 citations indexed

About

Clarissa Corinaldesi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Clarissa Corinaldesi has authored 21 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in Clarissa Corinaldesi's work include Systemic Sclerosis and Related Diseases (5 papers), Vitamin D Research Studies (3 papers) and Immune Cell Function and Interaction (3 papers). Clarissa Corinaldesi is often cited by papers focused on Systemic Sclerosis and Related Diseases (5 papers), Vitamin D Research Studies (3 papers) and Immune Cell Function and Interaction (3 papers). Clarissa Corinaldesi collaborates with scholars based in Italy, United States and United Kingdom. Clarissa Corinaldesi's co-authors include Clara Crescioli, Andrea Lenzi, Cristina Antinozzi, Luigi Di Luigi, Katia Basso, Riccardo Dalla‐Favera, Antony B. Holmes, Laura Pasqualucci, Silvia Migliaccio and Rahul Kumar and has published in prestigious journals such as Nature, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Clarissa Corinaldesi

18 papers receiving 579 citations

Peers

Clarissa Corinaldesi
Xiang Lin China
Larisa Ring Germany
Azeb Haile United States
Yuhu He China
Clarissa Corinaldesi
Citations per year, relative to Clarissa Corinaldesi Clarissa Corinaldesi (= 1×) peers Fábio Pereira

Countries citing papers authored by Clarissa Corinaldesi

Since Specialization
Citations

This map shows the geographic impact of Clarissa Corinaldesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarissa Corinaldesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarissa Corinaldesi more than expected).

Fields of papers citing papers by Clarissa Corinaldesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarissa Corinaldesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarissa Corinaldesi. The network helps show where Clarissa Corinaldesi may publish in the future.

Co-authorship network of co-authors of Clarissa Corinaldesi

This figure shows the co-authorship network connecting the top 25 collaborators of Clarissa Corinaldesi. A scholar is included among the top collaborators of Clarissa Corinaldesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarissa Corinaldesi. Clarissa Corinaldesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Qiong, Antony B. Holmes, Tongwei Mo, et al.. (2024). MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis. Nature Communications. 15(1). 7195–7195. 1 indexed citations
2.
Holmes, Antony B., Clarissa Corinaldesi, & Katia Basso. (2024). Single-Cell Transcriptomic Analysis of Normal and Malignant B Cells. Methods in molecular biology. 2865. 347–374.
3.
Fantini, Cristina, Clarissa Corinaldesi, Andrea Lenzi, Silvia Migliaccio, & Clara Crescioli. (2023). Vitamin D as a Shield against Aging. International Journal of Molecular Sciences. 24(5). 4546–4546. 45 indexed citations
4.
Bal, Élodie, Clarissa Corinaldesi, Antony B. Holmes, et al.. (2023). SUPER‐ENHANCER HYPERMUTATION IN DLBCL: ROLE OF ALTERATIONS IN THE GLUCOCORTICOID RECEPTOR PATHWAY. Hematological Oncology. 41(S2). 89–90.
5.
Colasanti, Tania, Katia Stefanantoni, Cristina Fantini, et al.. (2022). The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis. International Journal of Molecular Sciences. 23(17). 10150–10150. 7 indexed citations
6.
Bal, Élodie, Rahul Kumar, Mohammad Hadigol, et al.. (2022). Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature. 607(7920). 808–815. 74 indexed citations
7.
Corinaldesi, Clarissa, Antony B. Holmes, Qiong Shen, et al.. (2022). Tracking Immunoglobulin Repertoire and Transcriptomic Changes in Germinal Center B Cells by Single-Cell Analysis. Frontiers in Immunology. 12. 818758–818758. 9 indexed citations
8.
Ross, Rebecca, Clarissa Corinaldesi, G Migneco, et al.. (2021). Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Annals of the Rheumatic Diseases. 80(7). 920–929. 43 indexed citations
9.
Corinaldesi, Clarissa, Rebecca L. Ross, Giuseppina Abignano, et al.. (2021). Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. International Journal of Molecular Sciences. 22(6). 2894–2894. 12 indexed citations
10.
Wasson, Christopher W., et al.. (2020). Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts. Arthritis Research & Therapy. 22(1). 286–286. 32 indexed citations
11.
Holmes, Antony B., Clarissa Corinaldesi, Qiong Shen, et al.. (2020). Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome. The Journal of Experimental Medicine. 217(10). 115 indexed citations
12.
Antinozzi, Cristina, Clarissa Corinaldesi, Valeria Riccieri, et al.. (2018). OP0091 Cxcl10/cxcl11 serum measurement as potential predictor of systemic sclerosis. Annals of the Rheumatic Diseases. 77. 96–96.
13.
Giannattasio, Silvia, Clarissa Corinaldesi, Marta Colletti, et al.. (2018). The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence. Journal of Endocrinological Investigation. 42(6). 715–725. 33 indexed citations
14.
Corinaldesi, Clarissa, Giuseppina Abignano, Cristina Antinozzi, et al.. (2017). AB0029 Anti inflammatory effect of pde5 inhibition: scope for a new potential indication in ssc associated myositis. Annals of the Rheumatic Diseases. 76. 1057–1057. 1 indexed citations
15.
Vasile, M., Clarissa Corinaldesi, Cristina Antinozzi, & Clara Crescioli. (2017). Vitamin D in autoimmune rheumatic diseases: A view inside gender differences. Pharmacological Research. 117. 228–241. 34 indexed citations
16.
Marampon, Francesco, Cristina Antinozzi, Clarissa Corinaldesi, et al.. (2017). The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism. Endocrine. 59(3). 602–613. 17 indexed citations
17.
Antinozzi, Cristina, Francesco Marampon, Clarissa Corinaldesi, et al.. (2017). Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells. Journal of Endocrinological Investigation. 40(10). 1133–1143. 25 indexed citations
18.
Luigi, Luigi Di, Clarissa Corinaldesi, Marta Colletti, et al.. (2016). Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy. Inflammation. 39(3). 1238–52. 50 indexed citations
19.
Antinozzi, Cristina, Clarissa Corinaldesi, Carla Giordano, et al.. (2016). Potential role for the VDR agonist elocalcitol in metabolic control: Evidences in human skeletal muscle cells. The Journal of Steroid Biochemistry and Molecular Biology. 167. 169–181. 27 indexed citations
20.
Corinaldesi, Clarissa, Luigi Di Luigi, Andrea Lenzi, & Clara Crescioli. (2015). Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications. Journal of Endocrinological Investigation. 39(2). 143–151. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026